Clinical Trials

Continuous subcutaneous foslevodopa-foscarbidopa improved motor symptoms and reduced motor fluctuations compared with oral levodopa-carbidopa in patients with advanced Parkinson’s disease, according to a study in The Lancet Neurology.

Treatment with inebilizumab was associated with reduction in aquaporin-4 antibody titers and B cells for those with neuromyelitis optica spectrum disorder, according to an expert at ECTRIMS 2022.

Biomind Labs Inc. has announced positive initial results from the first part of its phase 2 trial of a novel liquid inhaled formulation of N,N-Dimethyltryptamine, or DMT, for treatment-resistant depression.

The demographic distribution of race and ethnicity in most randomized clinical trials does not reflect that of the U.S. population, according to a cross-sectional retrospective analysis.

Many contemporary clinical trials for metastatic renal cell carcinoma incorporate restrictive eligibility criteria, according to study results.

Beckley Psytech Ltd. announced that it has acquired clinical-stage life science company Eleusis Therapeutics Ltd., with the aim of bolstering its pipeline of psychedelic-based therapeutics.

WASHINGTON — Black and Latino patients are underrepresented in cirrhosis clinical trials, underpinning the need for systematic improvement, according to research presented at The Liver Meeting.

Racial and ethnic disparities in enrollment of patients to early-phase metastatic cancer-drug clinical trials worsened between 2000 and 2018, according to study results published in JAMA Network Open.

Biopharmaceutical company Aptinyx Inc. announced the finalization of a $5.6 million NIH grant for the development of a novel therapeutic for the treatment of opioid use disorder.

Panoramic Health announced the launch of Panoramic Science, its new clinical research division designed to improve kidney care innovation and outcomes, according to a press release.